We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

150 hedge funds and large institutions have $1.18B invested in Translate Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 21

27% more capital invested

Capital invested by funds: $936M → $1.18B (+$249M)

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

14% more funds holding

Funds holding: 132150 (+18)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

80% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $10.7M

Holders
150
Holders Change
+18
Holders Change %
+13.64%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
39
Increased
51
Reduced
44
Closed
21
Calls
$2.1M
Puts
$10.7M
Net Calls
-$8.55M
Net Calls Change
-$5.73M
Name Holding Trade Value Shares
Change
Change in
Stake
HT
101
HAP Trading
New York
$308K +$299K +16,703 New
Voloridge Investment Management
102
Voloridge Investment Management
Florida
$282K +$274K +15,311 New
BNP Paribas Asset Management
103
BNP Paribas Asset Management
France
$276K +$268K +15,000 New
WSTAM
104
Wilbanks Smith & Thomas Asset Management
Virginia
$271K +$263K +14,710 New
HighTower Advisors
105
HighTower Advisors
Illinois
$269K +$261K +14,600 New
GG
106
Golden Green
South Carolina
$269K +$262K +14,621 New
Simplex Trading
107
Simplex Trading
Illinois
$254K +$7.07K +395 +3%
BC
108
Bridgefront Capital
Texas
$254K +$247K +13,781 New
Mitsubishi UFJ Asset Management
109
Mitsubishi UFJ Asset Management
Japan
$253K +$80.2K +4,483 +49%
ASRS
110
Arizona State Retirement System
Arizona
$238K +$8.98K +502 +4%
Bank of Montreal
111
Bank of Montreal
Ontario, Canada
$227K +$132K +7,382 +233%
CCM
112
Copernicus Capital Management
California
$223K -$3.86M -215,628 -95%
Squarepoint
113
Squarepoint
New York
$216K -$1.41M -78,809 -87%
MIFH
114
Migdal Insurance & Financial Holdings
Israel
$216K +$210K +11,706 New
AC
115
Athanor Capital
New York
$208K +$202K +11,285 New
VEA
116
Virtus ETF Advisers
New York
$202K -$173K -9,640 -47%
AB
117
Amalgamated Bank
New York
$196K +$1.11K +62 +0.6%
Qube Research & Technologies (QRT)
118
Qube Research & Technologies (QRT)
United Kingdom
$194K +$188K +10,509 New
PCM
119
Pentwater Capital Management
Florida
$184K -$89.5K -5,000 -33%
TRCT
120
Tower Research Capital (TRC)
New York
$178K +$63.9K +3,570 +58%
BNP Paribas Financial Markets
121
BNP Paribas Financial Markets
France
$178K -$116K -6,454 -40%
OSAM
122
O'Shaughnessy Asset Management
Connecticut
$168K +$163K +9,117 New
AA
123
Ancora Advisors
Ohio
$125K +$25.1K +1,400 +26%
AIP
124
Ameritas Investment Partners
Nebraska
$107K
Skandinaviska Enskilda Banken (SEB)
125
Skandinaviska Enskilda Banken (SEB)
Sweden
$81K

TBIO Hedge Fund Activity: Q4 2020 in Review

150 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2020, worth a combined $1.18B — up 27% from $936M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TBIO positions and 21 closed out — a net gain of 18 holders — while 51 added to existing stakes and 44 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $34.5M. The largest seller was State Street, cutting an estimated $35.2M.

  • 150 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2020, up from 132 in Q3 2020.
  • Funds reported $1.18B of Translate Bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
  • 39 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2020 and 21 closed out, a net change of +18 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2020 was Invesco, an estimated $34.5M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2020 was State Street, an estimated $35.2M sold.

Based on aggregated 13F filings for Q4 2020.